What is ocular (retinal) migraine, what red‑flag features should prompt urgent evaluation, and how should it be diagnosed and managed in a young adult woman?

Ocular (Retinal) Migraine: Definition, Red Flags, Diagnosis, and Management

Retinal migraine is a rare migraine variant characterized by repeated attacks of fully reversible monocular visual disturbances (scintillations, scotoma, or blindness) lasting less than 1 hour, associated with migraine headache, and requires urgent evaluation to exclude sight-threatening vascular or embolic causes before diagnosis. 1, 2

What is Retinal Migraine?

Retinal migraine is distinct from typical migraine with visual aura because the visual symptoms are strictly monocular (affecting only one eye), not binocular. 1, 3 This is a critical diagnostic feature that differentiates it from the more common visual aura of migraine, which affects both eyes simultaneously due to occipital cortex involvement. 1

Key Clinical Features

• Monocular visual loss is the hallmark—patients experience partial or complete vision loss in one eye only, typically lasting less than 60 minutes. 4, 2
• Most commonly affects women in their second to third decade of life, with a strong predilection for those of childbearing age. 4, 2
• The majority of patients have a prior history of migraine with aura, contrary to what older diagnostic criteria suggested. 4
• The headache is typically ipsilateral (on the same side) as the visual loss. 5
• Visual symptoms are fully reversible according to current International Headache Society (ICHD-3) criteria. 1, 3

Critical Prognostic Warning

Nearly half of patients with recurrent transient monocular visual loss from retinal migraine subsequently develop permanent monocular visual loss, suggesting that irreversible visual loss is part of the retinal migraine spectrum and may represent an ocular form of migrainous infarction. 4, 2 This finding has profound implications for management urgency.

Red-Flag Features Requiring Urgent Evaluation

Any young adult woman presenting with monocular visual disturbances must undergo urgent ophthalmologic and neurologic evaluation to exclude life- or sight-threatening conditions before attributing symptoms to retinal migraine. 3, 6 Retinal migraine is a diagnosis of exclusion. 3, 5

Urgent Differential Diagnoses to Exclude

• Retinal artery occlusion or branch retinal artery occlusion—sudden painless monocular vision loss from embolic or thrombotic vascular occlusion; requires immediate evaluation for stroke risk and cardiac source. 6
• Amaurosis fugax from carotid stenosis—transient monocular blindness from emboli or hypoperfusion; mandates carotid imaging and stroke workup. 6
• Giant cell arteritis—in any patient over age 50 with new-onset headache and visual symptoms; requires immediate ESR/CRP and temporal artery biopsy to prevent bilateral blindness. 1, 7
• Retinal detachment or vitreous hemorrhage—requires urgent ophthalmologic examination. 6
• Optic neuritis—especially in young women; may herald multiple sclerosis; requires MRI brain with contrast. 7
• Transient ischemic attack (TIA) or stroke—although retinal migraine aura spreads gradually over ≥5 minutes whereas TIA symptoms have sudden simultaneous onset, any atypical features warrant urgent vascular imaging. 1

Specific Red Flags in This Population

• New-onset monocular visual loss after age 50 mandates immediate evaluation for giant cell arteritis and vascular causes. 1, 7
• Atypical aura lasting longer than 60 minutes suggests stroke or other serious intracranial pathology rather than retinal migraine. 1, 7
• Focal neurological symptoms beyond visual loss (weakness, sensory loss, speech disturbance) indicate possible stroke. 1, 7
• Thunderclap headache suggests subarachnoid hemorrhage. 1, 7
• Fever with neck stiffness indicates possible meningitis. 1, 7
• Progressive worsening of headache pattern over weeks to months suggests space-occupying lesion. 1, 7

Diagnostic Approach

History and Examination

Document the monocular nature of visual symptoms by asking the patient to cover each eye alternately during an attack—this is the single most important diagnostic maneuver to differentiate retinal migraine from binocular visual aura. 3, 6

• Record detailed attack characteristics: duration (<60 minutes), pattern of visual loss (scintillations, scotoma, complete blindness), relationship to headache onset (usually precedes or accompanies), and laterality. 1, 4, 5
• Assess for prior migraine history, particularly migraine with aura, as most retinal migraine patients have this background. 4
• Perform complete neurological examination to exclude focal deficits that would suggest alternative diagnoses. 1, 7
• Fundoscopic examination during an attack may reveal retinal artery vasoconstriction, supporting the diagnosis, though this is rarely captured. 5

Investigations

MRI brain with and without gadolinium contrast is the preferred imaging modality to exclude structural lesions, inflammatory processes (optic neuritis, demyelinating disease), vascular malformations, and neoplastic pathology that may present with visual symptoms. 7

• Urgent ophthalmologic consultation with dilated fundus examination, visual field testing, and optical coherence tomography (OCT) to exclude retinal vascular occlusion, detachment, or optic nerve pathology. 6, 5
• Carotid duplex ultrasound and cardiac evaluation (ECG, echocardiogram) to exclude embolic sources if any vascular risk factors are present. 6
• ESR and CRP if patient is over age 50 or has any features suggesting giant cell arteritis, recognizing that 10-36% of cases may have normal ESR. 7
• Neuroimaging is mandatory in any patient with monocular visual loss to exclude secondary causes before diagnosing retinal migraine. 7, 3

Diagnostic Criteria (ICHD-3)

Retinal migraine requires at least two attacks with all of the following 1:

• Fully reversible monocular visual disturbance (positive and/or negative visual phenomena) confirmed by examination during an attack or patient's drawing of monocular field defect
• Migraine headache fulfilling ICHD-3 criteria begins during the visual symptoms or follows them within 60 minutes
• At least two of the following: gradual spread over ≥5 minutes, duration 5-60 minutes, accompanied by headache
• Not better accounted for by another diagnosis after appropriate investigation

Management

Acute Treatment

Initiate migraine prophylactic treatment even if attacks are infrequent, given the high risk (nearly 50%) of permanent visual loss with recurrent episodes. 4 This recommendation is based on the observation that retinal migraine may represent a progressive vasculopathic process.

• NSAIDs (ibuprofen, diclofenac potassium, or aspirin) are first-line acute treatment for mild-to-moderate attacks. 1, 5
• Triptans are second-line for moderate-to-severe attacks or when NSAIDs fail, though theoretical concerns about vasoconstriction in retinal vessels exist. 1, 5 Some experts recommend caution with triptans in retinal migraine due to the proposed vasoconstrictive mechanism. 5
• Limit acute medication use to <10 days per month to prevent medication-overuse headache. 8

Prophylactic Treatment

All patients with retinal migraine should be offered prophylactic therapy to prevent permanent visual loss, regardless of attack frequency. 4 This is a departure from typical migraine management, where prophylaxis is reserved for frequent attacks.

• Topiramate is the only medication with proven efficacy in randomized controlled trials for chronic migraine; start at 25 mg at bedtime and titrate by 25 mg weekly to target dose of 100 mg daily. 8
• Propranolol, amitriptyline, or topiramate are evidence-based preventive options. 1
• Avoid sodium valproate in women of childbearing potential as it is absolutely contraindicated. 1

Special Considerations for Young Women

Combined hormonal contraceptives are contraindicated in women with migraine with aura due to increased stroke risk, and retinal migraine should be managed similarly given its vascular nature. 8

• Progestin-only methods are safe and recommended: progestin-only pills, depot medroxyprogesterone acetate injection, etonogestrel implant, or levonorgestrel IUD. 8
• Counsel patients about stroke risk associated with migraine with aura, particularly if other vascular risk factors (smoking, hypertension, obesity) are present. 8

Follow-Up and Monitoring

• Maintain a headache diary to track attack frequency, duration, and medication use. 1, 9
• Urgent ophthalmologic re-evaluation for any change in pattern, prolonged visual loss, or incomplete recovery. 6, 5
• Reassess diagnosis if attacks become more frequent, last longer than 60 minutes, or develop atypical features. 1, 9

Common Pitfalls

• Mistaking binocular visual aura for retinal migraine—always confirm monocular nature by having patient cover each eye during symptoms. 3, 6
• Failing to exclude vascular causes—retinal migraine is a diagnosis of exclusion; never diagnose without appropriate vascular and ophthalmologic workup. 3, 5
• Delaying prophylactic treatment—given the 50% risk of permanent visual loss, prophylaxis should be initiated early, not reserved for frequent attacks. 4
• Using triptans without caution—while effective for migraine, theoretical concerns exist about exacerbating retinal vasoconstriction. 5
• Prescribing combined hormonal contraceptives—these are contraindicated in migraine with aura and should be avoided in retinal migraine. 8